VELAN CAPITAL INVESTMENT MANAGEMENT LP BioCryst Pharmaceuticals, Inc. Transaction History

VELAN CAPITAL INVESTMENT MANAGEMENT LP portfolio value:

$2.83M
portfolio value

VELAN CAPITAL INVESTMENT MANAGEMENT LP quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 454K $12.6 225K
Q2 2022 share Increase 0.00% 225K shares 2.38M $10.58 225K